Gufic Biosciences Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results
Gufic Biosciences Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Gufic Biosciences Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results Gufic Biosciences Limited has scheduled a meeting of its Board of Directors on 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in the company's equity shares, which has been closed since 28th Sep'26 for designated persons and their immediate relatives, will remain closed until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith 路 17 Nov 2026
- Investor Presentation is attached herewith 路 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. 路 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith 路 15 Nov 2026
- Outcome of the Board of Directors Meeting held on Saturday, November 14, 2026 is attached herewith. 路 15 Nov 2026
- Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith 路 13 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith 路 16 Nov 2026
